241 related articles for article (PubMed ID: 33136764)
1. Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis.
Maqsood MH; Alam M; Atar D; Birnbaum Y
J Cardiovasc Pharmacol; 2021 Jan; 77(1):87-93. PubMed ID: 33136764
[TBL] [Abstract][Full Text] [Related]
2. Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis.
Misumida N; Harjai K; Kernis S; Kanei Y
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):280-5. PubMed ID: 26424094
[TBL] [Abstract][Full Text] [Related]
3. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
[TBL] [Abstract][Full Text] [Related]
4. Intravenous beta-blockers in ST-segment elevation myocardial infarction: A systematic review and meta-analysis.
Sterling LH; Filion KB; Atallah R; Reynier P; Eisenberg MJ
Int J Cardiol; 2017 Feb; 228():295-302. PubMed ID: 27866018
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis.
Konishi H; Miyauchi K; Kasai T; Tsuboi S; Ogita M; Naito R; Nishizaki Y; Okai I; Tamura H; Okazaki S; Isoda K; Daida H
Heart Vessels; 2016 Apr; 31(4):441-8. PubMed ID: 25573259
[TBL] [Abstract][Full Text] [Related]
6. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
[TBL] [Abstract][Full Text] [Related]
7. The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics.
Kristensen AMD; Munkhaugen J; Halvorsen S; Olsen MH; Bakken A; Sehested TSG; Ruddox V; Lange T; Fagerland MW; Torp-Pedersen C; Prescott E; Atar D
Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):175-183. PubMed ID: 38017624
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
Ozasa N; Kimura T; Morimoto T; Hou H; Tamura T; Shizuta S; Nakagawa Y; Furukawa Y; Hayashi Y; Nakao K; Matsuzaki M; Nobuyoshi M; Mitsudo K;
Am J Cardiol; 2010 Nov; 106(9):1225-33. PubMed ID: 21029817
[TBL] [Abstract][Full Text] [Related]
9. Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention.
Park H; Kim HK; Jeong MH; Cho JY; Lee KH; Sim DS; Yoon NS; Yoon HJ; Hong YJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kim YJ; Cho MC; Kim CJ;
J Cardiol; 2017 Jan; 69(1):216-221. PubMed ID: 27141820
[TBL] [Abstract][Full Text] [Related]
10. Combined assessment of left ventricular end-diastolic pressure and ejection fraction by left ventriculography predicts long-term outcomes of patients with ST-segment elevation myocardial infarction.
Saito D; Nakanishi R; Watanabe I; Yabe T; Okubo R; Amano H; Toda M; Ikeda T
Heart Vessels; 2018 May; 33(5):453-461. PubMed ID: 29143103
[TBL] [Abstract][Full Text] [Related]
11. Influence of left ventricular systolic function on the long-term benefit of beta-blockers after ST-segment elevation myocardial infarction.
Velásquez-Rodríguez J; Bruña V; Vicent L; Díez-Delhoyo F; Valero-Masa MJ; Sousa-Casasnovas I; Juárez M; Devesa C; Fernández-Avilés F; Martínez-Sellés M
Rev Port Cardiol (Engl Ed); 2021 Apr; 40(4):285-290. PubMed ID: 33642167
[TBL] [Abstract][Full Text] [Related]
12. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
Galea N; Dacquino GM; Ammendola RM; Coco S; Agati L; De Luca L; Carbone I; Fedele F; Catalano C; Francone M
Eur Radiol; 2019 May; 29(5):2369-2377. PubMed ID: 30552479
[TBL] [Abstract][Full Text] [Related]
13. Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials.
Hoedemaker NP; Roolvink V; de Winter RJ; van Royen N; Fuster V; García-Ruiz JM; Er F; Gassanov N; Hanada K; Okumura K; Ibáñez B; van 't Hof AW; Damman P
Eur Heart J Acute Cardiovasc Care; 2020 Aug; 9(5):469-477. PubMed ID: 30759994
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
15. Effects of Long-Term Carvedilol Therapy in Patients With ST-Segment Elevation Myocardial Infarction and Mildly Reduced Left Ventricular Ejection Fraction.
Amano M; Izumi C; Watanabe H; Ozasa N; Morimoto T; Bingyuan B; Suwa S; Miyake M; Tamura T; Nakagawa Y; Kadota K; Inuzuka Y; Minamimoto Y; Furukawa Y; Kaji S; Suzuki T; Akao M; Inada T; Kimura T;
Am J Cardiol; 2023 Jul; 199():50-58. PubMed ID: 37245250
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis.
Dahl Aarvik M; Sandven I; Dondo TB; Gale CP; Ruddox V; Munkhaugen J; Atar D; Otterstad JE
Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):12-20. PubMed ID: 30192930
[TBL] [Abstract][Full Text] [Related]
17. The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction.
Zhang S; Deng X; Yang W; Xia L; Yao K; Lu H; Ge L; Shen L; Sun A; Zou Y; Qian J; Ge J
BMC Cardiovasc Disord; 2020 Mar; 20(1):108. PubMed ID: 32131738
[TBL] [Abstract][Full Text] [Related]
18. Direct Admission Versus Interhospital Transfer for Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
Kawecki D; Gierlotka M; Morawiec B; Hawranek M; Tajstra M; Skrzypek M; Wojakowski W; Poloński L; Nowalany-Kozielska E; Gąsior M
JACC Cardiovasc Interv; 2017 Mar; 10(5):438-447. PubMed ID: 28216215
[TBL] [Abstract][Full Text] [Related]
19. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
[TBL] [Abstract][Full Text] [Related]
20. Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study.
Zhang Q; Qiao B; Han Y; Sun S; Wang B; Wei S
BMC Cardiovasc Disord; 2022 Nov; 22(1):463. PubMed ID: 36333668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
